Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners

Abstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteris...

Full description

Bibliographic Details
Main Authors: Khadija Benallel, Wafaa Mansouri, Jalal Salim, Roukaya Benjelloun, Mohamed Kadiri
Format: Article
Language:English
Published: SpringerOpen 2023-05-01
Series:Middle East Current Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s43045-023-00313-5
_version_ 1797823022204190720
author Khadija Benallel
Wafaa Mansouri
Jalal Salim
Roukaya Benjelloun
Mohamed Kadiri
author_facet Khadija Benallel
Wafaa Mansouri
Jalal Salim
Roukaya Benjelloun
Mohamed Kadiri
author_sort Khadija Benallel
collection DOAJ
description Abstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteristics. To date, no study has been conducted in Morocco on the prescribing habits of psychiatrists toward patients with schizophrenia. The objectives of our survey are to identify the molecules most prescribed by psychiatrists in Morocco for patients with schizophrenia and to determine the most common therapeutic strategies. Results Our survey recruited 72 Moroccan psychiatrists. The median age was 36.5 years. 72.2% were women, and 37.5% had between 5 and 10 years of practice. More than two-thirds were practicing in the public sector in big cities. Olanzapine was an antipsychotic prescribed as first-line treatment for a patient with schizophrenia. For the majority, the most frequent combination was atypical antipsychotics with conventional neuroleptics. On the one hand, most psychiatrists reported prescribing neuroleptics long-acting injectable (neuroleptic LAIs). In the other hand, almost half of the participants had never prescribed second-generation antipsychotic long-acting injectables (SGA-LAIs). The high cost (77.8%), lack of availability of the product in certain sectors (33.3%), lack of therapeutic choice (26.4%), and lack of patient profile that could use the drug (23.6%), were among the strong reasons given for not prescribing SGA-LAIs. Conclusions The treatment decision for patients with schizophrenia differs from one clinician to the other. It depends on various factors that may be related to the psychiatrist, the patient, and to the drug.
first_indexed 2024-03-13T10:18:02Z
format Article
id doaj.art-86061dc8f79540bc88761d92abdc23c2
institution Directory Open Access Journal
issn 2090-5416
language English
last_indexed 2024-03-13T10:18:02Z
publishDate 2023-05-01
publisher SpringerOpen
record_format Article
series Middle East Current Psychiatry
spelling doaj.art-86061dc8f79540bc88761d92abdc23c22023-05-21T11:06:57ZengSpringerOpenMiddle East Current Psychiatry2090-54162023-05-013011810.1186/s43045-023-00313-5Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitionersKhadija Benallel0Wafaa Mansouri1Jalal Salim2Roukaya Benjelloun3Mohamed Kadiri4Psychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Cheikh Khalifa International University Hospital, Mohammed VI University of Health SciencesPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatAbstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteristics. To date, no study has been conducted in Morocco on the prescribing habits of psychiatrists toward patients with schizophrenia. The objectives of our survey are to identify the molecules most prescribed by psychiatrists in Morocco for patients with schizophrenia and to determine the most common therapeutic strategies. Results Our survey recruited 72 Moroccan psychiatrists. The median age was 36.5 years. 72.2% were women, and 37.5% had between 5 and 10 years of practice. More than two-thirds were practicing in the public sector in big cities. Olanzapine was an antipsychotic prescribed as first-line treatment for a patient with schizophrenia. For the majority, the most frequent combination was atypical antipsychotics with conventional neuroleptics. On the one hand, most psychiatrists reported prescribing neuroleptics long-acting injectable (neuroleptic LAIs). In the other hand, almost half of the participants had never prescribed second-generation antipsychotic long-acting injectables (SGA-LAIs). The high cost (77.8%), lack of availability of the product in certain sectors (33.3%), lack of therapeutic choice (26.4%), and lack of patient profile that could use the drug (23.6%), were among the strong reasons given for not prescribing SGA-LAIs. Conclusions The treatment decision for patients with schizophrenia differs from one clinician to the other. It depends on various factors that may be related to the psychiatrist, the patient, and to the drug.https://doi.org/10.1186/s43045-023-00313-5Prescribing habitsMoroccan psychiatristSchizophreniaLong-acting injectableSecond generation antipsychotic
spellingShingle Khadija Benallel
Wafaa Mansouri
Jalal Salim
Roukaya Benjelloun
Mohamed Kadiri
Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
Middle East Current Psychiatry
Prescribing habits
Moroccan psychiatrist
Schizophrenia
Long-acting injectable
Second generation antipsychotic
title Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
title_full Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
title_fullStr Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
title_full_unstemmed Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
title_short Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
title_sort prescribing habits of moroccan psychiatrists toward patients with schizophrenia about 72 practitioners
topic Prescribing habits
Moroccan psychiatrist
Schizophrenia
Long-acting injectable
Second generation antipsychotic
url https://doi.org/10.1186/s43045-023-00313-5
work_keys_str_mv AT khadijabenallel prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners
AT wafaamansouri prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners
AT jalalsalim prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners
AT roukayabenjelloun prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners
AT mohamedkadiri prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners